One Program, Many CDMOs: Managing Multi-Partner Strategies

As development and manufacturing science for new drugs and therapies grow more complex and compressed for time, biotechs and pharma organizations are often forced to separate work across multiple CDMOs and diverse locations, for example drug substance in Asia and drug product in the U.S.

Outsourced Pharma Chief Editor Jeff Buguliskis and our expert panelists tackle how to coordinate activities and workflow between external partners and locations, and manage accountability and documentation. They will also talk about the real-world cost of all this outsourcing coordination – and the risk involved.

Registration is free thanks to sponsor Thermo Fisher Scientific.